Successful regression of metaplastic triple-negative breast cancer with neoadjuvant chemotherapy and surgical intervention: A case report

This case highlights the potential efficacy of combining neoadjuvant chemotherapy, surgery, and adjuvant therapy in the management of MBC, emphasizing the need for careful monitoring of clinical, histological, and imaging data to guide treatment decisions for this rare cancer subtype.

Authors

Razan Moghnieh
Mabel Aoun (ORCID: https://orcid.org/0000-0001-9893-5514)
Hadi Farhat (ORCID: https://orcid.org/0000-0003-1515-7038)
Yehya Tlaiss (ORCID: https://orcid.org/0009-0003-5266-3690)
Esther Häge (ORCID: https://orcid.org/0000-0002-4838-8804)
Nour Bachaalany

Institutions

University of Balamand (LB)
Lebanese Hospital Geitaoui-University Medical Center (LB)

Publication Details

Journal: Medicine
Published: 2025-04-18
DOI: https://doi.org/10.1097/md.0000000000042167
Citations: 1
Primary Topic: Breast Cancer Treatment Studies
Type: article
Field-Weighted Citation Impact: 0.94

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Successful regression of metaplastic triple-negative breast cancer with neoadjuvant chemotherapy and surgical intervention: A case report

Razan Moghnieh, Mabel Aoun, Hadi Farhat, Yehya Tlaiss et al.

Apr 18, 2025

1 citations

Medicine

Breast Cancer Treatment Studies

0.94

article

Successful regression of metaplastic triple-negative breast cancer with neoadjuvant chemotherapy and surgical intervention: A case report

Razan Moghnieh, Mabel Aoun, Hadi Farhat, Yehya Tlaiss, Esther Häge, Nour Bachaalany

April 18, 2025article en

1 citations

Abstract

This case highlights the potential efficacy of combining neoadjuvant chemotherapy, surgery, and adjuvant therapy in the management of MBC, emphasizing the need for careful monitoring of clinical, histological, and imaging data to guide treatment decisions for this rare cancer subtype.

MedicineVol. 104(16)

University of Balamand (LB), Lebanese Hospital Geitaoui-University Medical Center (LB)

Openalex Percentile: Top 26%

Breast Cancer Treatment Studies

0.94

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.